Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
100%
Patient
88%
Budesonide/Formoterol
77%
Therapeutic Procedure
66%
Disease Severity
55%
Symptom
33%
Lung
22%
Clinical Trial
22%
Drug Therapy
11%
Corticosteroid
11%
Forced Expiratory Volume
11%
Post-Hoc Analysis
11%
Tiotropium Bromide
11%
Peak Expiratory Flow
11%
Nursing and Health Professions
Obstructive Lung Disease
100%
Budesonide/Formoterol
77%
Inpatient
66%
Disease Severity
55%
Placebo
55%
Symptom
33%
Clinical Outcome
11%
Corticosteroid
11%
Post Hoc Analysis
11%
Forced Expiratory Volume
11%
Randomization
11%
Tiotropium Bromide
11%
Procedures
11%
Peak Expiratory Flow
11%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Budesonide Plus Formoterol
77%
Disease Severity
55%
Symptom
33%
Agonist
22%
Corticosteroid
11%